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INTRODUCTION
Otitis media (OM) is a worldwide health problem with high 
prevalence, which consumes many medical resources. It is a 
multifactorial disorder in which bacterial infection plays an im-
portant role. Chronic otitis media (COM) is followed by irrevers-
ible tissue damage and destruction of the middle ear structures, 
with the possibility of complications under the maintenance of 
inflammation. To date, only few genetic studies have been per-
formed in OM, but mostly in COM with effusion and recurrent 
OM (ROM), and the results have been ambiguous [1-5]. Inflam-
matory mediators such as cytokines play a crucial role in the ini-
tial stage of inflammation [1] caused by bacteria [6-8] and their 
role in OM have been suggested [9,10]. The interleukin-1 beta 
(IL-1β) is a mediator of both bacterial and viral OM and has in-
fluence on many different target cells, thus it stimulates proin-
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Objectives. Chronic otitis media (COM) is followed by irreversible tissue damage and destruction of the middle ear struc-
tures, with the possibility of complications under the maintenance of inflammation. Inflammatory mediators such as 
cytokines play a crucial role in the initial stage of inflammation. The aim of this study was to evaluate the association 
of the polymorphisms in two innate immunity/inflammation cascade genes from interleukin-1 (IL-1) gene cluster 
with COM with regard to cholesteatoma. 
Methods. In the cross-sectional case-control study, DNA samples were collected from 189 patients with COM and 119 
controls from a population of Serbia. The +3953 C/T (rs1143634), TaqI polymorphism in interleukin-1 beta (IL-1β) 
gene and 86 bp variable number tandem repeat (VNTR, rs2234663) polymorphism in the IL-1 receptor antagonist 
(IL-1RA) gene were analyzed by polymerase chain reaction. 
Results. The IL-1β TaqI polymorphism was not significantly different in patients compared with the control group. The sig-
nificant difference between patients and controls was observed for both, genotype and allele frequencies of IL-1RA 
VNTR polymorphism (chi-square P<0.01). We found that carriers of IL-1RA allele 2 (odds ratio, 0.47; 95% confi-
dence interval, 0.29 to 0.76; P=0.004) have a favorable association with COM, using multivariate logistic analysis 
that included both polymorphisms, age and sex. The IL-1RA allele frequency distribution was significantly different 
with regard to cholesteatoma.
Conclusion. The carriers of allele 2 of VNTR IL-1RA polymorphism had a decreased odds ratio for COM, which is in agree-
ment with findings in other inflammatory disease and its previous association with higher IL-1RA levels. Possible 
down-regulation of IL-1 mediated proinflammatory signaling pathways via IL-1RA in COM as well as results of our 
study should be further investigated and replicated. 
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flammatory network in the middle ear and could induce activa-
tion and proliferation of fibroblast and growth of osteoclasts in 
the middle ear possibly leading to fibrosis and bone erosion 
[1,11]. Cholesteatomas, the epidermal lesions in the middle ear 
that lead to erosion of bones, are commonly associated with 
ROM and often contains bacteria. It was recently shown that in-
flammation and innate immunity system play an important role 
in cholesteatomas, as well [12,13].
The number of studies revealed the association of IL-1 gene 
cluster with a predisposition to certain inflammatory diseases, 
but only a few had been performed in OM [14,15]. The genetic 
variant +3953 (rs1143634) in IL-1β has been suggested to influ-
ence production of IL-1β protein [16] while the variable number 
tandem repeat (VNTR) variant (rs2234663) in anti-inflammato-
ry IL-1 receptor antagonist (IL-1RA, also called IL-1RN) has 
been proposed to influence expression of IL-1RA protein [17]. 
The aim of this study was to evaluate the association of the 
polymorphisms in two innate immunity/inflammation cascade 
genes from a single cluster (IL-1β +3953 C/T and IL-1RA 86 bp 
VNTR) with COM with regard to cholesteatoma. Bacterial flora 
and basic biochemical parameters were also analyzed with re-
gard to the presence of cholesteatoma and genotypes of investi-
gated polymorphisms. 
MATERIALS AND METHODS
Subjects
This cross-sectional case-control study was approved by the Eth-
ics Committee of the Clinical Center of Serbia (approval No. 
29/VI-15). All participants (or parents of children) gave their 
signed informed consent for participation in the study.
All of the patients underwent surgery due to the symptoms of 
chronic middle ear disease. The 189 consecutive patients with 
COM without effusion were collected at the Clinic of Otorhino-
laryngology and Maxillofacial Surgery, Clinical Centre of Serbia, 
Belgrade from 2011 to 2013 to participate in the study. The 
blood samples for genetic analysis were collected prior middle 
ear surgery. The children suspected of having head and neck 
anomalies, systemic disease or congenital or acquired immuno-
deficiency were excluded from the study. In order to evaluate 
the most common etiological agent in patients with multiple 
bacteria in cultures were excluded from the study. The patient 
group consisted of 34 children (aged between 2 and 18 years, 
mostly >5 years old) and 155 adults (aged 41±19 years). In 
children, male sex was predominantly present (61.76%) while 
in adults, females predominated (54.36%). In total, there were 
47.08% males and 52.92% females in the patient group. Ac-
cording to the ear pathology group consisted of patients with 
nonsuppurative COM with tympanic membrane retraction 
without cholesteatoma, patients with suppurative COM and 
tympanic membrane perforation and patients with COM with 
cholesteatoma.
From the adults undergoing annual medical check-up at Oc-
cupational Medical Centers, Belgrade, Serbia, who underwent 
clinical and biochemical examination, 119 (aged 41±15 years) 
that were without previous history of COM and allergies and 
evidence of any chronic inflammatory disease such as, rheuma-
toid arthritis, systemic lupus or allergies, asthma, inflammatory 
bowel disease and Crohn disease, renal failure or diabetes melli-
tus were recruited as controls. In controls otomicroscopy, pure 
tone audiometry and tympanometry were done. The appear-
ance of the tympanic membrane under a microscope was un-
eventful, audiogram showed normal hearing and type A tympa-
nogram the proper mobility of the tympanic membrane. The re-
sults of these examinations have pointed to a healthy middle 
ear.
Diagnosis of COM was established by otomicroscopy, tympa-
nometry in retracted tympanic membrane, pure tone audiome-
try in patients over five or objective audiometry in younger 
children. Computed tomography of temporal bone was per-
formed in cholesteatoma patients. Patients with tympanic mem-
brane retraction (COM non-suppurativa) underwent surgery us-
ing different techniques depending of retractions’ stage and au-
ditory ossicle conditions. Retracted tympanic membranes were 
classified according to the Erasmus classification for pars tensa 
retraction and Tos classification for attic retractions [18,19]. The 
techniques used were aeration tube insertion alone for the first 
stage of retraction, or combined with resection of the retraction 
and grafting with cartilage or fascia, or only grafting. Patients 
with COM suppurativa underwent tympanoplasty wall up with 
antrotomy or mastoidectomy with tympanic perforation graft-
ing [20]. Patients with cholesteatoma were treated with two 
stage tympanoplasty procedure. There were no positive data 
about allergy per anamnesis or clinical examination in the 
whole patient group. Samples of middle ear secretion were tak-
en with sterile cotton swabs during surgery, and bacterial cul-
tures were done immediately after sampling, inoculated to 
blood agar medium and MacConkey medium. The cultures were 
incubated for 24 hours at 35ºC, and bacteria were identified by 
Gram staining and biochemical tests. Standard biochemical 
measurements of blood parameters were performed for all pa-
tients.
   The allele 2 of interleukin-1 receptor antagonist variable num-
ber tandem repeat is favorably associated with chronic otitis 
media.
   The interleukin-1 receptor antagonist allele frequencies were 
significantly different with regard to cholesteatoma.
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Genetic analysis
Genomic DNA was isolated from peripheral blood samples col-
lected with ethylenediaminetetraacetic acid and purified by the 
proteinase K/phenol extraction method. The +3953 C/T poly-
morphism in IL-1β gene and 86 bp VNTR polymorphism in the 
IL-1RA gene were analyzed by the polymerase chain reaction 
method on an ABI 9700 Thermal Cycler (GeneAmp; Applied 
Biosystems, Foster City, CA, USA) in a 20 μL reaction mixture 
containing 200 ng of genomic DNA using the following primers: 
IL-1β (forward 5´-GTATATGCTCAGTGTCCTC-3´ and reverse 
5´-CATGGAGAATTAGCAAGCTG-3´), IL1-RA (forward 5´-CT-
CAGCAACACTCCTAT-3´ and reverse 5´-TCCTGGTCTGCAG-
GTAA-3´). The genotypes for IL-1β +3953 C/T, TaqI polymor-
phism were visualized on 8% polyacrylamide gel after over-
night restriction digestion with TaqI enzyme and for IL-1RA 86 
bp VNTR polymorphism on 1.8% agarose gel.
Statistical analysis
The frequencies of genotypes and alleles were determined by 
the gene counting method. To compare the obtained frequency 
distribution of genotypes in the control group with the expected 
values of the Hardy-Weinberg equilibrium, we applied the chi-
square test. For test of independence between two categorical 
variables, the Pearson chi-square test was used. Multiple logistic 
regression analysis was performed in order to assess if IL-1β and 
IL-1RA polymorphisms are independently associated with sus-
ceptibility to COM (expressed in terms of adjusted odds ratio 
[OR] and its 95% confidence interval [CI]). In all tests, the value 
of P<0.05 was considered significant. All statistical analyses 
were performed using Statistica software 5.0 (Statsoft Inc., Palo 
Alto, CA, USA). The statistical power of the study for the ob-
served effect of polymorphism on susceptibility to COM was 
calculated using the power and sample size calculation (v3.0.43) 
[21].
RESULTS
Genotypes and alleles in COM patients and controls
The prevalence of VNTR IL-1RA and IL-1β TaqI genotypes and 
alleles in COM patients and controls were shown in Table 1. We 
didn’t find the deviation from Hardy-Weinberg equilibrium in 
the investigated groups. Distribution of genotypes and alleles of 
IL-1β TaqI polymorphism were not significantly different in pa-
tients compared with the control group. The significant differ-
ence between patients and controls was observed for both, gen-
otype and allele frequencies of IL-1RA VNTR polymorphism 
(P<0.01) (Table 1). By univariate analysis we calculated crude 
OR for IL-1RA allele 2 containing genotypes (OR, 0.48; 95% 
CI, 0.29 to 0.78; P=0.003), the IL-1 TaqI 22 genotype (OR, 1.36; 
95% CI, 0.44 to 4.23; P=0.597), male sex (OR, 0.68; 95% CI, 
0.41 to 1.10; P=0.114) and age (OR, 0.99; 95% CI, 0.98 to 
1.01; P=0.473). We further found that IL-1RA allele 2 contain-
ing genotypes (OR, 0.47; 95% CI, 0.29 to 0.76; P=0.004) had 
an independent favorable association with COM, using multi-
variate logistic analysis that included polymorphisms (IL-1β TaqI 
and IL-1RA VNTR genotypes grouped with regard to allele 2 
presence or absence), age and sex (Table 2). We had the study 
power of 86% for the observed association with an OR=0.47, 
at the significance level of 0.05 and the given sample size. 
Genotypes and alleles in COM patients without  
cholesteatoma and COM patients with cholesteatoma
The prevalence of VNTR IL-1RA and IL-1β TaqI genotypes in 
COM patients without cholesteatoma and COM patients with 
cholesteatoma was not significantly different (Table 3). We found 
a significant difference in the IL-1RA VNTR allele frequency 
distribution between two groups of patients (P=0.034) (Table 3), 
with allele 1 predominance in COM patients without cholestea-
toma and allele 2 predominance in COM patients with choles-
Table 1. Genotype and allele frequencies of the IL-1RA VNTR and IL-1β TaqI gene polymorphisms in COM patients and controls
Genotype COM (n=189) Control (n=119) P-valuea)
Allele frequency
Allele COM Control P-valuea)
IL-1RA VNTR <0.01
   11 133 (70.4)   60 (50.4) 1 0.81 0.71
   12   38 (20.1)   40 (33.6) 2 0.16 0.26 0.005
   13   5 (2.7)   8 (6.7) 0.006 3 0.03 0.03
   22 10 (5.3) 11 (9.3)
   23  1 (0.5) 0
   33  2 (1.0) 0
IL-1β TaqI
   11 110 (58.2) 61 (51.3) 1 0.77 0.73 0.285
   12  70 (37.1) 51 (42.8) 0.487 2 0.23 0.27
   22 9 (4.7) 7 (5.9)
Values are presented as number (%).
IL-1RA, interleukin-1 receptor antagonist; VNTR, variable number tandem repeat; IL-1β, interleukin-1 beta; COM, chronic otitis media.
a)P-value (chi-square) of the difference in genotype and allele frequency distribution. 
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teatoma. Subgroups of COM patients, those without cholestea-
toma and those with cholesteatoma had significantly decreased 
IL-1RA allele 2 containing genotypes in comparison to controls 
(P=0.003 and P=0.021, respectively), but there was no differ-
ence between two groups of patients (allele 2+: non-cholestea-
toma vs. cholesteatoma, 24.4% vs. 28.6%; P=0.560). 
DISCUSSION
The aim of this study was to evaluate the association of the 
polymorphisms in two innate immunity/inflammation cascade 
genes from a single cluster (IL-1β +3953 C/T, TaqI and IL-1RA 
86 bp VNTR) with COM with regard to cholesteatoma. Genes 
that control the production of cytokines are the first choice can-
didate genes for COM, same as for a variety of chronic inflam-
matory and autoimmune human diseases [22]. But up to date 
not many studies have been performed using a candidate gene 
approach for COM/ROM. The main finding of this study was 
that allele 2 of VNTR IL-1RA polymorphism was favorably as-
sociated with COM. Previously, only the Finnish study reported 
an association between IL-1α and ROM in children without al-
lergic disorders [14]. The lack of association between IL-1β 
+3953 C/T polymorphism with COM, in this study, is in agree-
ment with previous results [14,15]. Moreover, previously we 
didn’t find the association of this polymorphism with other 
chronic inflammatory disease, multiple sclerosis, in patients from 
Serbia [23]. Still, the association between acute OM symptom 
severity and IL-1β +3953 polymorphism, in a subset of children 
with more severe tympanic membrane involvement, was found 
recently [24]. In this study, we have shown the significant favor-
able effect of IL1-RA VNTR allele 2 toward susceptibility to 
COM, adjusted for IL-1β TaqI polymorphism, age and sex. Pre-
viously the same polymorphism has not been associated with 
recurrent acute OM in Finnish population [14]. The IL-1RA al-
lele 2 was suggested to be associated with higher IL-1RA levels 
[17,25], which can lead to down-regulation of IL-1 mediated 
proinflammatory signaling pathways thus becoming the reason-
able candidate gene in inflammatory diseases. It is known that 
complex formed by IL-1 cytokines and receptors recruits intra-
cellular signaling, including MyD88-dependent activation of NF-
κB, p38, JNK, and ERK [26]. Novel results showed that patho-
gens that causes pneumonia and OM, exert proinflammatory ef-
fects through the NF-κB pathway via TLR2, MyD88, and IRAK4 
[27]. The IL-1RA after binding to IL-1 receptor does not activate 
intracellular signaling pathways thus exerts anti-inflammatory 
role. It was recently shown that blockage of the IL-1α/PI3K/NF-
κB signaling pathway may be a major mechanism by which IL-
1RA inhibits proinflammatory effects [28]. Recent meta-analysis 
in chronic periodontitis suggested a decreased risk for aggressive 
periodontitis in allele 2 carriers in Caucasians and significantly 
higher risk for chronic periodontitis in Asians [29]. It has been 
Table 3. Genotype frequencies of the IL-1RA VNTR and IL-1β TaqI gene polymorphisms in COM patients with and without cholesteatoma
Genotype
Without cholesteatoma 
(n=119)
With cholesteatoma 
(n=70)
P-valuea)
Allele frequency
Allele Without cholesteatoma With cholesteatoma P-valuea)
IL-1RA VNTR
   11 88 (74.0) 45 (63.6) 1 0.85 0.76
   12 25 (21.0) 13 (18.2) 2 0.13 0.19 0.034
   13 1 (0.8) 4 (5.4) 0.211 3 0.02 0.05
   22 4 (3.4) 6 (9.9)
   23 0 1 (1.8)
   33 1 (0.8) 1 (1.8)
IL-1β TaqI
   11 66 (55.5) 45 (64.3) 1 0.74 0.81 0.115
   12 45 (37.8) 24 (34.3) 0.189 2 0.26 0.19
   22 8 (6.7) 1 (1.4)
Values are presented as number (%).
IL-1RA, interleukin-1 receptor antagonist; VNTR, variable number tandem repeat; IL-1β, interleukin-1 beta; COM, chronic otitis media.
a)P-value (chi-square) of the difference in genotype and allele frequency distribution.
Table 2. Odds ratio for COM in regard to IL-1RA VNTR genotypes grouped by allel 2 status 
IL-1RA VNTR COM Control Unadjusted OR (95% CI) P-value Adjusted OR (95% CI)a) P-value
Allele 2– 140 (74.1) 68 (57.1) - - - -
Allele 2+  49 (25.9) 51 (42.9) 0.48 (0.29–0.78) 0.003 0.47 (0.29–0.76) 0.004
Values are presented as number (%) unless otherwise indicated.
COM, chronic otitis media; IL-1RA, interleukin-1 receptor antagonist; VNTR, variable number tandem repeat; OR, odds ratio; CI, confidence interval; IL-1β, 
interleukin-1 beta.
a)Adjusted for sex, age and IL-1β TaqI polymorphism.
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already known that IL1-RA VNTR allele frequency may vary by 
ethnicity and previously the association of allele 2 with chronic 
rhinosinusitis was found in Taiwanese, but not in Caucasians 
[30]. In multiple sclerosis, another chronic inflammatory disease, 
allele 2 had been associated with a more benign form of disease 
in patients from Italy [31] and had a protective role for its sus-
ceptibility in Serbian population [23]. Although IL-1RA has 
been present in the research of inflammatory disease for more 
than a decade only recently, it was thoroughly described as an 
active counterpart of IL-1β actions, which diminishes deleteri-
ous effects on metabolic processes in downstream organs and 
tissue damage [32]. Hereof we investigated its copy number 
variant with regard to cholesteatoma in patients with COM and 
we show the significant difference in allele frequency, with allele 
2 predominance in COM patients with cholesteatoma. Molecu-
lar mechanisms and genetic basis of both, COM and cholestea-
toma and their potential clinical aggressiveness are challenging 
subject in current research [33] and has yet to be resolved. Re-
cently, an extensive review was published in order to gather ex-
isting literature regarding heritability of cholesteatoma [34]. The 
heritable component of cholesteatoma etiology was suggested, 
although insufficiency in relevant literature suggests the need for 
a stronger body of evidence.
The major limitation of most of the genetic studies in COM, 
including this study was the limited number of cases included. 
This should be overcome in future studies and multicentric ap-
proach would be the most valuable. The more genetic data we 
gather along with clinical data, the more about the genetic archi-
tecture of COM will be visible. COM is a complex and multifac-
torial disease with both genetic and environmental factors un-
derlying its pathophysiology. The drawback inherent from ana-
lyzing the limited number of factors, as in this study and most 
of the studies up to date, should be overcome too, and the mul-
tifactorial models of COM susceptibility and complications 
should be defined. Nevertheless, the retrospectively calculated 
study power for the significant association (86%) suggests that 
current results should be taken into account for further research, 
primarily because the VNTRs, such as IL-1RA VNTR, were not 
investigated in the SNP genome wide association studies.
In conclusion, the carriers of allele 2 of VNTR IL-1RA poly-
morphism had a decreased risk for COM, which is in agreement 
with findings in other inflammatory disease and its previous as-
sociation with higher IL-1RA levels. Possible down-regulation of 
IL-1 mediated proinflammatory signaling pathways via IL-1RA 
in COM as well as results of our study should be further investi-
gated and replicated.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was re-
ported.
ACKNOWLEDGMENTS
This research was conducted as part of the OI 175085, financed 
by the Ministry of Education, Science and Technological Devel-
opment of the Republic of Serbia.
REFERENCES
1. Smirnova MG, Kiselev SL, Gnuchev NV, Birchall JP, Pearson JP. 
Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, 
interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogene-
sis of the otitis media with effusion. Eur Cytokine Netw. 2002 Apr-
Jun;13(2):161-72.
2. Daly KA, Brown WM, Segade F, Bowden DW, Keats BJ, Lindgren 
BR, et al. Chronic and recurrent otitis media: a genome scan for sus-
ceptibility loci. Am J Hum Genet. 2004 Dec;75(6):988-97.
3. Segade F, Daly KA, Allred D, Hicks PJ, Cox M, Brown M, et al. As-
sociation of the FBXO11 gene with chronic otitis media with effu-
sion and recurrent otitis media: the Minnesota COME/ROM Family 
Study. Arch Otolaryngol Head Neck Surg. 2006 Jul;132(7):729-33.
4. Allen EK, Chen WM, Weeks DE, Chen F, Hou X, Mattos JL, et al. A 
genome-wide association study of chronic otitis media with effusion 
and recurrent otitis media identifies a novel susceptibility locus on 
chromosome 2. J Assoc Res Otolaryngol. 2013 Dec;14(6):791-800.
5. Einarsdottir E, Hafren L, Leinonen E, Bhutta MF, Kentala E, Kere J, 
et al. Genome-wide association analysis reveals variants on chromo-
some 19 that contribute to childhood risk of chronic otitis media 
with effusion. Sci Rep. 2016 Sep;6:33240.
6. Dagan R, Leibovitz E, Leiberman A, Yagupsky P. Clinical significance 
of antibiotic resistance in acute otitis media and implication of anti-
biotic treatment on carriage and spread of resistant organisms. Pedi-
atr Infect Dis J. 2000 May;19(5 Suppl):S57-65.
7. Liederman EM, Post JC, Aul JJ, Sirko DA, White GJ, Buchman CA, 
et al. Analysis of adult otitis media: polymerase chain reaction ver-
sus culture for bacteria and viruses. Ann Otol Rhinol Laryngol. 1998 
Jan;107(1):10-6.
8. Kim H, Choo OS, Jang JH, Park HY, Choung YH. Chronological 
changes in microbial profiles in external and middle ear diseases: a 
20-year study in Korea. Eur Arch Otorhinolaryngol. 2017 Mar;274(3): 
1375-81.
9. Lindberg K, Rynnel-Dagoo B, Sundqvist KG. Cytokines in nasopha-
ryngeal secretions; evidence for defective IL-1 beta production in 
children with recurrent episodes of acute otitis media. Clin Exp Im-
munol. 1994 Sep;97(3):396-402.
10. Sato K, Kawana M, Nonomura N, Nakano Y. Course of IL-1beta, IL-
6, IL-8, and TNF-alpha in the middle ear fluid of the guinea pig otitis 
media model induced by nonviable Haemophilus influenzae. Ann 
Otol Rhinol Laryngol. 1999 Jun;108(6):559-63.
11. Sudhoff HH, Klenke C. Inflammation cascade related to biofilms in 
otitis media. In: Kania R, Ars B, editors. Biofilms in otitis. Amster-
dam: Kugler Publications; 2015. p. 157-70.
12. Leichtle A, Klenke C, Ebmeyer J, Daerr M, Bruchhage KL, Hoff-
mann AS, et al. NOD-like receptor signaling in cholesteatoma. Biomed 
Res Int. 2015;2015:408169.
13. Klenke C, Janowski S, Borck D, Widera D, Ebmeyer J, Kalinowski J, 
et al. Identification of novel cholesteatoma-related gene expression 
signatures using full-genome microarrays. PLoS One. 2012;7(12): 
e52718.
14. Joki-Erkkila VP, Puhakka H, Hurme M. Cytokine gene polymor-
phism in recurrent acute otitis media. Arch Otolaryngol Head Neck 
Živković M et al. IL-1 β, IL-1RA Variants in Chronic Otitis Media    123
Surg. 2002 Jan;128(1):17-20.
15. Patel JA, Nair S, Revai K, Grady J, Saeed K, Matalon R, et al. Associ-
ation of proinflammatory cytokine gene polymorphisms with sus-
ceptibility to otitis media. Pediatrics. 2006 Dec;118(6):2273-9.
16. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI poly-
morphism in the human interleukin-1 beta (IL-1 beta) gene corre-
lates with IL-1 beta secretion in vitro. Eur J Clin Invest. 1992 Jun; 
22(6):396-402.
17. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine produc-
tion by normal human monocytes: inter-subject variation and rela-
tionship to an IL-1 receptor antagonist (IL-1Ra) gene polymor-
phism. Clin Exp Immunol. 1995 Feb;99(2):303-10.
18. Borgstein J, Gerritsma TV, Wieringa MH, Bruce IA. The Erasmus at-
electasis classification: proposal of a new classification for atelectasis 
of the middle ear in children. Laryngoscope. 2007 Jul;117(7):1255-9.
19. Tos M. Upon the relationship between secretory otitis in childhood 
and chronic otitis and its sequelae in adults. J Laryngol Otol. 1981 
Oct;95(10):1011-22.
20. Jesic SD, Dimitrijevic MV, Nesic VS, Jotic AD, Slijepcevic NA. Tem-
poralis fascia graft perforation and retraction after tympanoplasty 
for chronic tubotympanic otitis and attic retraction pockets: factors 
associated with recurrence. Arch Otolaryngol Head Neck Surg. 2011 
Feb;137(2):139-43.
21. Dupont WD, Plummer WD Jr. Power and sample size calculations: a 
review and computer program. Control Clin Trials. 1990 Apr;11(2): 
116-28.
22. Hollegaard MV, Bidwell JL. Cytokine gene polymorphism in human 
disease: on-line databases, Supplement 3. Genes Immun. 2006 Jun; 
7(4):269-76.
23. Dincic E, Zivkovic M, Stankovic A, Obradovic D, Alavantic D, Kostic 
V, et al. Association of polymorphisms in CTLA-4, IL-1ra and IL-
1beta genes with multiple sclerosis in Serbian population. J Neuro-
immunol. 2006 Aug;177(1-2):146-50.
24. McCormick DP, Grady JJ, Diego A, Matalon R, Revai K, Patel JA, et 
al. Acute otitis media severity: association with cytokine gene poly-
morphisms and other risk factors. Int J Pediatr Otorhinolaryngol. 
2011 May;75(5):708-12.
25. Schrijver HM, van As J, Crusius JB, Dijkstra CD, Uitdehaag BM. In-
terleukin (IL)-1 gene polymorphisms: relevance of disease severity 
associated alleles with IL-1beta and IL-1ra production in multiple 
sclerosis. Mediators Inflamm. 2003 Apr;12(2):89-94.
26. Palomo J, Dietrich D, Martin P, Palmer G, Gabay C. The interleukin 
(IL)-1 cytokine family: balance between agonists and antagonists in 
inflammatory diseases. Cytokine. 2015 Nov;76(1):25-37.
27. Wang Y, Wang Q, Li Y, Chen Y, Shao J, Nick N, et al. Mmm-derived 
lipid-associated membrane proteins activate IL-1β production through 
the NF-κB pathway via TLR2, MyD88, and IRAK4. Sci Rep. 2017 
Jun;7(1):4349.
28. Ma J, Sun X, Guo T, Su H, Chen Q, Gong Z, et al. Interleukin-1 re-
ceptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-
κβ pathway in human colon cancer cell. Cancer Manag Res. 2017 
Oct;9:481-93.
29. Ding C, Zhao L, Sun Y, Li L, Xu Y. Interleukin-1 receptor antagonist 
polymorphism (rs2234663) and periodontitis susceptibility: a meta-
analysis. Arch Oral Biol. 2012 Jun;57(6):585-93.
30. Cheng YK, Lin CD, Chang WC, Hwang GY, Tsai SW, Wan L, et al. In-
creased prevalence of interleukin-1 receptor antagonist gene poly-
morphism in patients with chronic rhinosinusitis. Arch Otolaryngol 
Head Neck Surg. 2006 Mar;132(3):285-90.
31. Sciacca FL, Ferri C, Vandenbroeck K, Veglia F, Gobbi C, Martinelli F, 
et al. Relevance of interleukin 1 receptor antagonist intron 2 poly-
morphism in Italian MS patients. Neurology. 1999 Jun;52(9):1896-8.
32. Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes 
and cardiovascular disease. Eur J Clin Invest. 2017 Aug;47(8):600-
11.
33. Hamed MA, Nakata S, Shiogama K, Suzuki K, Sayed RH, Nishimura 
Y, et al. Cytokeratin 13, cytokeratin 17, and Ki-67 expression in hu-
man acquired cholesteatoma and their correlation with its destruc-
tive capacity. Clin Exp Otorhinolaryngol. 2017 Sep;10(3):213-20.
34. Jennings BA, Prinsley P, Philpott C, Willis G, Bhutta MF. The genetics 
of cholesteatoma: a systematic review using narrative synthesis. Clin 
Otolaryngol. 2018 Feb;43(1):55-67.
